[1] BUSCH K, THIMME R. Natural history of chronic hepatitis B virusinfection[J]. Med Microbiol Immunol, 2015, 204 (1) :5-10.
|
[2] KRAWCZYK M, MULLENBACH R, WEBER SN, et al. Genome-wide association studies and genetic risk assessment of liver dis-eases[J]. Nat Rev Gastroenterol Hepatol, 2010, 7 (12) :669-681.
|
[3] JAKOBSSON M, SCHOLZ SW, SCHEET P, et al. Genotype, haplotype and copy-number variation in worldwide humanpopulations[J]. Nature, 2008, 451 (7181) :998-1003.
|
[4] HOLLOX EJ, HOH BP. Human gene copy number variationand infectious disease[J]. Hum Genet, 2014, 133 (10) :1217-1233.
|
[5] BUDZKO L, MARCINKOWSKA-SWOJAK M, JACKOWIAK P, et al. Copy number variation of genes involved in the hepatitisC virus-human interactome[J]. Sci Rep, 2016, 6:31340.
|
[6] LIU SJ, YAO L, DING D, et al. CCL3L1 copy number varia-tion and susceptibility to HIV-1 infection:A meta-analysis[J]. PLo S One, 2010, 5 (12) :e15778.
|
[7] BONVIN M, GREEVE J. Hepatitis B:Modern concepts inpathogenesis-APOBEC3 cytidine deaminases as effectors ininnate immunity against the hepatitis B virus[J]. Curr Opin In-fect Dis, 2008, 21 (3) :298-303.
|
[8] KITAMURA S, ODE H, NAKASHIMA M, et al. The APO-BEC3C crystal structure and the interface for HIV-1 Vif bind-ing[J]. Nat Struct Mol Biol, 2012, 19 (10) :1005-1010.
|
[9] CHEN YM, HU J, CAI XF, et al. APOBEC3B edits HBV DNAand inhibits HBV replication during reverse transcription[J].Antiviral Res, 2018, 149:16-25.
|
[10] PRASETYO AA, SARYATUN R, REVIONO, et al. The APO-BEC3B deletion polymorphism is associated with prevalence ofhepatitis B virus, hepatitis C virus, Torque Teno virus, andToxoplasma gondii co-infection among HIV-infected individ-uals[J]. J Clin Virol, 2015, 70:67-71.
|
[11] DU RQ, LU CC, JIANG ZW, et al. Efficient typing of copynumber variations in a segmental duplication-mediated rear-rangement hotspot using multiplex competitive amplification[J]. Hum Genet, 2012, 57 (8) :545-551.
|
[12] EZZIKOURI S, KITAB B, REBBANI K, et al. Polymorphic APO-BEC3 modulates chronic hepatitis B in Moroccan population[J].J Viral Hepat, 2013, 20 (10) :678-686.
|
[13] SINGH H, MARATHE SD, NAIN S, et al. APOBEC3B deletionimpacts on susceptibility to acquire HIV-1 and its advance-ment among individuals in western India[J]. APMIS, 2016, 124 (10) :881-887.
|
[14] IMAHASHI M, IZUMI T, WATANABE D, et al. Lack of associationbetween intact/deletion polymorphisms of the APOBEC3B geneand HIV-1 risk[J]. PLo S One, 2014, 9 (3) :e92861.
|
[15] ZHANG TW, CAI JQ, CHANG J, et al. Evidence of associa-tions of APOBEC3B gene deletion with susceptibility to persis-tent HBV infection and hepatocellular carcinoma[J]. Hum MolGenet, 2013, 22 (6) :1262-1269.
|
[16] KIDD JM, NEWMAN TL, TUZUN E, et al. Population stratifica-tion of a common APOBEC gene deletion polymorphism[J].PLo S Genet, 2007, 3 (4) :e63.
|